define the game; play to win
A firm for ventures at inflexion points
We enter the room before the lawyers do — shaping deals from conception through close, defining terms and building value before execution begins.
As strategic advisor and IP counsel, Sylvain Roy brings 25+ years of transaction experience across North America and Europe.
Our edge is the combination of business and IP law, venture operation experience, and valuation expertise — applied as complementary disciplines, each informing the other.
When outcomes are uncertain, we help you identify and implement the right path — whether through licensing, strategic partnerships, M&A, equity financing, or exits. We work with founders, investors, and research institutions wherever IP, data, or technology is the core asset.
As a company grows, weakly defined IP ownership, know-how boundaries, data control, supplier dependence, and internal misalignment become business risks. Growth magnifies what was never properly structured.
We put the legal and strategic architecture in place so the business can scale while preserving control over its assets and negotiating position.
Advisory on business secrets, strategic control, and value preservation, including co-authorship in Business Secrets Management (Springer, 2025).
A company has developed valuable IP, but the path forward is unclear. Full commercialization may be too early, licensing underprepared, and acquisition not yet realistic.
We assess the strategic and economic value of the asset, then identify the most executable monetization path — licensing, partnership, financing, or sale.
IP valuation advisory for a global clientele in technology and media. Startup valuation through SRV's proprietary BVM methodology — 17 years of practice, 350+ mandates.
A research sponsor, researcher, and institution want to work together, but ownership is not clear. Background IP, foreground IP, data rights, publication rights, and future commercialization are all in play — and delay increases risk.
We structure the collaboration before misalignment hardens into conflict, so the parties can build, fund, and commercialize on a workable basis.
Technology transfer and strategic IP advisory in university and research environments, including EPFL and CERN-related work.
The technology is credible, but conventional funding is not yet aligned with the venture's stage. Beyond early research, still too early for standard investment terms.
We help design a financing structure that reflects the real risk profile, development stage, and strategic objective of each party involved.
Structuring innovative donation-financing approaches for health and research-driven ventures, including HOP Tech and projects with McGill University Health Centre (RI-MUHC).
SELECTED CLIENTS
